Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
JW Marriott Tokyo: an elegant retreat amid whirlwind of the city - 2Fundamental Home Exercise center Hardware: Amplify Your Exercises
- 3IDF destroys two-kilometer-long Gaza terror tunnel in Beit Lahiya
- 4International issues on the agenda as Frances's Macron visits China
- 5Must-Sit in front of the Programs from Europe and the US
- The 15 Most Compelling Books in History
- Bold Colors, Playful Shapes, Handmade Textures: This Mexico City Home Is 100% Joyful!
- Israeli lawmakers pass bill reviving death penalty for terrorists
- From White Elephant to Favorite Things parties, here are all the rules you need to know every kind of gift exchange
- The most effective method to Pick the Best Wellbeing Highlights for Seniors in SUVs
- Colleges say foreign students feel 'unwelcome' in the U.S. amid big drop in international enrollment, new survey finds
- Vote In favor of Your #1 Method for diminishing Pressure
- What are the health benefits of whole milk for kids?
- Why screening for the deadliest cancer in the U.S. misses most cases
